These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7757521)

  • 1. Beneficial effects of a novel platelet-activating factor receptor antagonist, ST 899, on endotoxin-induced shock in mice.
    Ruggiero V; Chiapparino C; Manganello S; Pacello L; Foresta P; Martelli EA
    Shock; 1994 Oct; 2(4):275-80. PubMed ID: 7757521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
    Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
    Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of macrophage-activating cytokines is beneficial in the acute septic response.
    Redmond HP; Chavin KD; Bromberg JS; Daly JM
    Ann Surg; 1991 Oct; 214(4):502-8; discussion 508-9. PubMed ID: 1659339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock.
    Araújo CV; Barbosa-Filho JM; Cordeiro RS; Tibiriçá E
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):267-75. PubMed ID: 11284440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin.
    Ferguson-Chanowitz KM; Katocs AS; Pickett WC; Kaplan JB; Sass PM; Oronsky AL; Kerwar SS
    J Infect Dis; 1990 Nov; 162(5):1081-6. PubMed ID: 2230235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
    Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C
    J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
    Kruse-Elliott KT; Albert DH; Summers JB; Carter GW; Zimmerman JJ; Grossman JE
    Shock; 1996 Apr; 5(4):265-73. PubMed ID: 8721386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interrelation between TNF, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model.
    Engelberts I; von Asmuth EJ; van der Linden CJ; Buurman WA
    Lymphokine Cytokine Res; 1991 Apr; 10(1-2):127-31. PubMed ID: 1873355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
    Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
    J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.
    Mózes T; Zijlstra FJ; Heiligers JP; Tak CJ; Ben-Efraim S; Bonta IL; Saxena PR
    Br J Pharmacol; 1991 Nov; 104(3):691-9. PubMed ID: 1797328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with a platelet-activating factor antagonist has little protective effects during endotoxic shock in the dog.
    Spapen H; Zhang H; Verhaeghe V; Rogiers P; Cabral A; Vincent JL
    Shock; 1997 Sep; 8(3):200-6. PubMed ID: 9377167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432.
    Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G
    Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
    Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
    Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of SRI 63-675, a competitive platelet-activating factor receptor-antagonist, in the generalized Shwartzman reaction.
    Gans RO; DiPirro JC; Ueda Y; Niesen N; Lee KH; Brentjens JR
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):229-42. PubMed ID: 7812674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
    Albert DH; Magoc TJ; Tapang P; Luo G; Morgan DW; Curtin M; Sheppard GS; Xu L; Heyman HR; Davidsen SK; Summers JB; Carter GW
    Eur J Pharmacol; 1997 Apr; 325(1):69-80. PubMed ID: 9151941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.
    Carrick JB; Morris DD; Moore JN
    Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.